Biolin Scientific AB (publ) is a Swedish public limited company listed on the Nasdaq OMX Small Cap in Stockholm, Sweden. Full financial reports are currently published only in the Swedish language. For full financial information in the Swedish language, visit the For Investors pages on this site. Under these pages, summary financial information is presented in the English language.

Over the last 5 years, our average growth rate in net sales has been over 70 %. Biolin Scientific has gone from being a loss-making, development intense company, to being a profit generating group with a balanced focus on sales, marketing and development.

During the last 2 years, Biolin Scientific has grown considerably and improved earnings quarter by quarter.

Our long-term targets are to continue to grow with over 25 % per year and to reach an EBITDA margin over 20 %. For 2010, we target an increase in net sales of 20 % and an EBITDA margin of 15 %.

Learn more:
- Company Introduction
- Abstract from Interim Report Q2-2010